Indonesia’s exclusive C-Level Closed Door Biopharma Roundtable is designed to bridge the gap between Indonesia’s biopharma leadership and global solution providers, with the goal of expediting drug development processes across discovery, clinical trials, manufacturing, and commercialisation.

As Indonesia looks to strengthen its position in Southeast Asia’s biopharma ecosystem, this roundtable provides a strategic, closed-door setting for decision-makers to share challenges, explore innovative solutions, and forge collaborations. By bringing together the biopharma leaders and solution providers, the roundtable serves as a catalyst for overcoming barriers in speed-to-market, compliance, localisation, and scalability.